APA (7th ed.) Citation

Moriarty, P. M., Thompson, P. D., Cannon, C. P., Guyton, J. R., Bergeron, J., Zieve, F. J., . . . Gipe, D. A. (2015). Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. Journal of clinical lipidology, 9(6), 758-769. https://doi.org/10.1016/j.jacl.2015.08.006

Chicago Style (17th ed.) Citation

Moriarty, Patrick M., et al. "Efficacy and Safety of Alirocumab Vs Ezetimibe in Statin-intolerant Patients, with a Statin Rechallenge Arm: The ODYSSEY ALTERNATIVE Randomized Trial." Journal of Clinical Lipidology 9, no. 6 (2015): 758-769. https://doi.org/10.1016/j.jacl.2015.08.006.

MLA (9th ed.) Citation

Moriarty, Patrick M., et al. "Efficacy and Safety of Alirocumab Vs Ezetimibe in Statin-intolerant Patients, with a Statin Rechallenge Arm: The ODYSSEY ALTERNATIVE Randomized Trial." Journal of Clinical Lipidology, vol. 9, no. 6, 2015, pp. 758-769, https://doi.org/10.1016/j.jacl.2015.08.006.